Skip to main content

Table 1 (abstract PReS24-ABS-1180). See description

From: Proceedings of the 31st European Paediatric Rheumatology Congress: part 2

Parameter, Me (25%;75)

JIA-associated uveitis,

n=111 (%)

CIA,

n= 39 (%)

p

Type of uveitis, n (%)

   

- Anterior*

82 (73)

19 (49)

0.032

- Parsplanitis

4 (4)

2 (5)

 

- Posterior

4 (4)

4 (10)

 

- Panuveitis

21 (19)

14 (36)

 

Time before methotrexate, years

1.6 (0.1; 2.3)

2.7 (0.4; 4.2)

0.005

Time before remission on methotrexate, years

0.75 (0.17; 0.42)

0.2 (0.1; 0.3)

0.07

Flares on methotrexate, n (%)

27/58 (47)

12/16 (75)

0.044

Time before flare, years

1.0 (0.75; 1.7)

1.2 (0.3; 1.4)

0.3

Time before biologics since uveitis onset, years

2.7 (0.7; 4.0)

4.0 (1.1; 6.2)

0.03

Time before remission on biologics, years

0.3 (0.1; 0.6)

0.2 (0.1; 0.3)

0.080

Flare on biologics, n (%)

22/55 (40)

11/24 (46)

0.629

Time before flare on biologics, years

1.8 (1.0; 2.7)

1.2 (0.3; 1.9)

0.100